NCT03371004View on ClinicalTrials.gov

DM-CHOC-PEN Plus Radiation for Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 5, 2016

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
Advanced Cancer
Interventions
DRUG

4-Demethyl-4-cholesteryloxycarbonylpenclomedine

IV administration as described

Trial Locations (3)

48336

Detroit Clinical Research Centers, Detroit

70112

Tulane University Medical Center, New Orleans

Tulane University Medical School, New Orleans

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

DEKK-TEC, Inc.

INDUSTRY

NCT03371004 - DM-CHOC-PEN Plus Radiation for Brain Tumors | Biotech Hunter | Biotech Hunter